| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Myriad Genetics, Inc. (MYGN) has 9 insiders with recent SEC Form 4 filings, including 3 buys and 12 sells. MYGN is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 1.07M | $4.81M | - | |
| Other | 573.4K | $2.58M | - | |
| COO | 381.8K | $1.72M | - | |
| Other | 251.9K | $1.13M | - | |
| Other | 170.2K | $765.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 22, 2018 | King Gary A. | Exec. VP International Ops | Sale+OE | 34,445 | $39.67 | $1,366,588.35 | -12.4% | |
| Jan 22, 2018 | Marsh Richard M | E.v.p., General Counsel | Sale+OE | 37,654 | $40.25 | $1,515,611.15 | -23.9% | |
| Jan 18, 2018 | King Gary A. | Exec. VP International Ops | Sale+OE | 3,120 | $38.12 | $118,934.40 | -2.5% | |
| Jan 18, 2018 | Marsh Richard M | E.v.p., General Counsel | Sale+OE | 40,000 | $38.25 | $1,530,000.00 | -25.0% | |
| Jan 12, 2018 | Marsh Richard M | E.v.p., General Counsel | Sell | 13,759 | $36.25 | $498,763.75 | -10.3% | |
| Dec 14, 2017 | Gilbert Walter Phd | Director | Sell | 7,500 | $33.19 | $248,925.00 | -21.6% | |
| Dec 11, 2017 | Dreismann Heinrich | Director | Sell | 6,000 | $33.50 | $201,000.00 | -15.1% | |
| Nov 13, 2017 | Ford Alexander | President, Mgl | Sell | 3,031 | $31.64 | $95,897.20 | -3.8% | |
| Sep 1, 2017 | Henderson John T65 | Director | Sale+OE | 30,000 | $30.30 | $909,040.00 | -19.0% | |
| Feb 23, 2017 | Henderson John T65 | Director | Buy | 6,000 | $18.66 | $111,930.20 | +5.1% |